RJH Industries

RJH Biosciences is a Canadian biotechnology company specializing in the development of novel delivery systems for nucleic acid therapeutics, including siRNA, mRNA, and plasmid DNA. The company's core technology involves polymer-based carriers (lipopolymers) designed to overcome the challenges of delivering genetic material into primary human cells and immune cells. RJH Biosciences offers a range of transfection reagents for research and development, while also advancing its own preclinical programs in oncology (leukemia, breast cancer) and immuno-inflammatory diseases. The company operates as both a product provider for the life sciences research market and a developer of clinical-grade delivery platforms for pharmaceutical partnerships.